Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 164-174

  Singh, Satwinder Kaur ^a   Stephani, Johannes ^b   Schaefer, Martin ^b   Kalay, Hakan ^a   García Vallejo, Juan J ^a   den Haan, Joke ^a   Saeland, Eirikur ^a   Sparwasser, Tim ^b   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

Antigen presentation; DC SIGN; Glycans

Indexed keywords

CD209 ANTIGEN; CYTOKINE; GLYCAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGOSACCHARIDE; OVALBUMIN; VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL MATURATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DESIGN; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD15; BONE MARROW CELLS; CARBOHYDRATE METABOLISM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CROSS-PRIMING; DENDRITIC CELLS; GLYCOCONJUGATES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; POLYSACCHARIDES; RECEPTORS, CELL SURFACE;

MURINAE; MUS MUSCULUS;

EID: 70450277084     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.026     Document Type: Review

References (64)

1. Aarnoudse C.A., Bax M., Sanchez-Hernandez M., Garcia-Vallejo J.J., and van Kooyk Y. Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. Int. J. Cancer 122 (2008) 839-846
2. Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., and van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170 (2003) 1635-1639
3. Ariizumi K., Shen G.L., Shikano S., Ritter III R., Zukas P., Edelbaum D., Morita A., and Takashima A. Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J. Biol. Chem. 275 (2000) 11957-11963
4. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76 (1998) 34-40
5. Bergman M.P., Engering A., Smits H.H., van Vliet S.J., van Bodegraven A.A., Wirth H.P., Kapsenberg M.L., Vandenbroucke-Grauls C.M., van Kooyk Y., and Appelmelk B.J. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200 (2004) 979-990
6. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196 (2002) 1627-1638
7. Buchsel P.C., and DeMeyer E.S. Dendritic cells: emerging roles in tumor immunotherapy. Clin. J. Oncol. Nurs. 10 (2006) 629-640
8. Burgdorf S., Kautz A., Bohnert V., Knolle P.A., and Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316 (2007) 612-616
9. Burgdorf S., Lukacs-Kornek V., and Kurts C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176 (2006) 6770-6776
10. Caminschi I., Corbett A.J., Zahra C., Lahoud M., Lucas K.M., Sofi M., Vremec D., Gramberg T., Pohlmann S., Curtis J., Handman E., van Dommelen S.L., Fleming P., Degli-Esposti M.A., Shortman K., and Wright M.D. Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN. Int. Immunol. 18 (2006) 741-753
11. Carter R.W., Thompson C., Reid D.M., Wong S.Y., and Tough D.F. Induction of CD8+ T cell responses through targeting of antigen to Dectin-2. Cell Immunol. 239 (2006) 87-91
12. Carter R.W., Thompson C., Reid D.M., Wong S.Y., and Tough D.F. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 177 (2006) 2276-2284
13. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., Steinman R.M., and Nussenzweig M.C. Differential antigen processing by dendritic cell subsets in vivo. Science 315 (2007) 107-111
14. Engering A., Geijtenbeek T.B., van Vliet S.J., Wijers M., van Liempt E., Demaurex N., Lanzavecchia A., Fransen J., Figdor C.G., Piguet V., and van Kooyk Y. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168 (2002) 2118-2126
15. Engering A.J., Cella M., Fluitsma D., Brockhaus M., Hoefsmit E.C., Lanzavecchia A., and Pieters J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27 (1997) 2417-2425
16. Fajardo-Moser M., Berzel S., and Moll H. Mechanisms of dendritic cell-based vaccination against infection. Int. J. Med. Microbiol. 298 (2008) 11-20
17. Feinberg H., Mitchell D.A., Drickamer K., and Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294 (2001) 2163-2166
18. Figdor C.G., de Vries I.J., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10 (2004) 475-480
19. Garcia-Vallejo J.J., Van Het Hof B., Robben J., Van Wijk J.A., van Die I., Joziasse D.H., and Van Dijk W. Approach for defining endogenous reference genes in gene expression experiments. Anal. Biochem. 329 (2004) 293-299
20. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., and Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
21. Geijtenbeek T.B., van Vliet S.J., Engering A., t Hart B.A., and van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22 (2004) 33-54
22. Geijtenbeek T.B., van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., and van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197 (2003) 7-17
23. Gramberg T., Caminschi I., Wegele A., Hofmann H., and Pohlmann S. Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens. Virology 345 (2006) 482-491
24. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
25. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19 (2001) 47-64
26. Hitchen P.G., Mullin N.P., and Taylor M.E. Orientation of sugars bound to the principal C-type carbohydrate-recognition domain of the macrophage mannose receptor. Biochem. J. 333 Pt 3 (1998) 601-608
27. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
28. Idoyaga J., Cheong C., Suda K., Suda N., Kim J.Y., Lee H., Park C.G., and Steinman R.M. Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180 (2008) 3647-3650
29. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
30. Kalergis A.M., and Ravetch J.V. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med. 195 (2002) 1653-1659
31. Kato M., McDonald K.J., Khan S., Ross I.L., Vuckovic S., Chen K., Munster D., MacDonald K.P., and Hart D.N. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int. Immunol. 18 (2006) 857-869
32. Kretz-Rommel A., Qin F., Dakappagari N., Torensma R., Faas S., Wu D., and Bowdish K.S. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. J. Immunother. 30 (2007) 715-726
33. Kurts C., Miller J.F., Subramaniam R.M., Carbone F.R., and Heath W.R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188 (1998) 409-414
34. Lam J.S., Mansour M.K., Specht C.A., and Levitz S.M. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J. Immunol. 175 (2005) 7496-7503
35. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
36. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., and Steinman R.M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151 (2000) 673-684
37. Mansour M.K., Latz E., and Levitz S.M. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176 (2006) 3053-3061
38. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
39. Mitchell D.A., Fadden A.J., and Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276 (2001) 28939-28945
40. Moris A., Nobile C., Buseyne F., Porrot F., Abastado J.P., and Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103 (2004) 2648-2654
41. Moris A., Pajot A., Blanchet F., Guivel-Benhassine F., Salcedo M., and Schwartz O. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108 (2006) 1643-1651
42. O'Keeffe M., Hochrein H., Vremec D., Caminschi I., Miller J.L., Anders E.M., Wu L., Lahoud M.H., Henri S., Scott B., Hertzog P., Tatarczuch L., and Shortman K. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 196 (2002) 1307-1319
43. Park C.G., Takahara K., Umemoto E., Yashima Y., Matsubara K., Matsuda Y., Clausen B.E., Inaba K., and Steinman R.M. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13 (2001) 1283-1290
44. Pereira C.F., Torensma R., Hebeda K., Kretz-Rommel A., Faas S.J., Figdor C.G., and Adema G.J. In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model. J. Immunother. 30 (2007) 705-714
45. Powlesland A.S., Ward E.M., Sadhu S.K., Guo Y., Taylor M.E., and Drickamer K. Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. J. Biol. Chem. 281 (2006) 20440-20449
46. Ramakrishna V., Treml J.F., Vitale L., Connolly J.E., O'Neill T., Smith P.A., Jones C.L., He L.Z., Goldstein J., Wallace P.K., Keler T., and Endres M.J. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J. Immunol. 172 (2004) 2845-2852
47. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995) 389-400
48. Schaefer M., Reiling N., Fessler C., Stephani J., Taniuchi I., Hatam F., Yildirim A.O., Fehrenbach H., Walter K., Ruland J., Wagner H., Ehlers S., and Sparwasser T. Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection. J. Immunol. 180 (2008) 6836-6845
49. Schuurhuis D.H., Ioan-Facsinay A., Nagelkerken B., van Schip J.J., Sedlik C., Melief C.J., Verbeek J.S., and Ossendorp F. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 168 (2002) 2240-2246
50. Sheng K.C., Pouniotis D.S., Wright M.D., Tang C.K., Lazoura E., Pietersz G.A., and Apostolopoulos V. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 118 (2006) 372-383
51. Singh S.K., Streng-Ouwehand I., Litjens M., Weelij D.R., Garcia-Vallejo J.J., van Vliet S.J., Saeland E., and van Kooyk Y. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol. Immunol. 46 (2009) 1240-1249
52. Suzuki N., Yamamoto K., Toyoshima S., Osawa T., and Irimura T. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen. J. Immunol. 156 (1996) 128-135
53. Tacken P.J., de Vries I.J.M., Gijzen K., Joosten B., Wu D., Rother R.P., Faas S.J., Punt C.J., Torensma R., Adema G.J., and Figdor C.G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106 (2005) 1278-1285
54. Tacken P.J., de Vries I.J.M., Torensma R., and Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7 (2007) 790-802
55. Takahara K., Yashima Y., Omatsu Y., Yoshida H., Kimura Y., Kang Y.S., Steinman R.M., Park C.G., and Inaba K. Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. Int. Immunol. 16 (2004) 819-829
56. Tsuiji M., Fujimori M., Ohashi Y., Higashi N., Onami T.M., Hedrick S.M., and Irimura T. Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J. Biol. Chem. 277 (2002) 28892-28901
57. Valladeau J., Ravel O., zutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., Duvert-Frances V., Vincent C., Schmitt D., Davoust J., Caux C., Lebecque S., and Saeland S. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (2000) 71-81
58. van Kooyk Y., and Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3 (2003) 697-709
59. van Liempt E., Bank C.M., Mehta P., Garcia-Vallejo J.J., Kawar Z.S., Geyer R., Alvarez R.A., Cummings R.D., van Kooyk Y., and van Die I. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett. 580 (2006) 6123-6131
60. van Liempt E., van Vliet S.J., Engering A., Garcia Vallejo J.J., Bank C.M., Sanchez-Hernandez M., van Kooyk Y., and van Die I. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 44 (2007) 2605-2615
61. van Vliet S.J., van Liempt E., Saeland E., Aarnoudse C.A., Appelmelk B., Irimura T., Geijtenbeek T.B., Blixt O., Alvarez R., van Die I., and van Kooyk Y. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int. Immunol. 17 (2005) 661-669
62. Wang J., Zhang Y., Wei J., Zhang X., Zhang B., Zhu Z., Zou W., Wang Y., Mou Z., Ni B., and Wu Y. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 121 (2007) 174-182
63. Willment J.A., Gordon S., and Brown G.D. Characterization of the human beta-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem. 276 (2001) 43818-43823
64. Yang L., Yang H., Rideout K., Cho T., Joo K.I., Ziegler L., Elliot A., Walls A., Yu D., Baltimore D., and Wang P. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat. Biotechnol. 26 (2008) 326-334